141 related articles for article (PubMed ID: 7694305)
1. Effects of sennosides and nonanthranoid laxatives on cytochemistry of epithelial cells in rat colon.
Yang K; Fan K; Mengs U; Lipkin M
Pharmacology; 1993 Oct; 47 Suppl 1():196-204. PubMed ID: 7694305
[TBL] [Abstract][Full Text] [Related]
2. Effects of sennosides A + B and bisacodyl on rat large intestine.
Leng-Peschlow E
Pharmacology; 1989; 38(5):310-8. PubMed ID: 2762373
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium picosulfate, bisacodyl and sennoside in cultured human, rat and rabbit liver cells.
Nishikawa J; Kast A
Arzneimittelforschung; 1981; 31(6):1010-3. PubMed ID: 7196230
[TBL] [Abstract][Full Text] [Related]
4. Light and electron-microscopic changes in the colon of the guinea pig after treatment with anthranoid and non-anthranoid laxatives.
Mengs U; Rudolph RL
Pharmacology; 1993 Oct; 47 Suppl 1():172-7. PubMed ID: 8234426
[TBL] [Abstract][Full Text] [Related]
5. In vivo motility of rat colon chronically pretreated with sennosides.
Fioramonti J; Dupuy C; Buéno L
Pharmacology; 1993 Oct; 47 Suppl 1():155-61. PubMed ID: 8234424
[TBL] [Abstract][Full Text] [Related]
6. Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation.
Geboes K; Nijs G; Mengs U; Geboes KP; Van Damme A; de Witte P
Pharmacology; 1993 Oct; 47 Suppl 1():187-95. PubMed ID: 8234428
[TBL] [Abstract][Full Text] [Related]
7. bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM)-the active metabolite of the laxatives bisacodyl and sodium picosulfate-enhances contractility and secretion in human intestine in vitro.
Krueger D; Demir IE; Ceyhan GO; Zeller F; Schemann M
Neurogastroenterol Motil; 2018 Jul; 30(7):e13311. PubMed ID: 29441646
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment with anthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon.
Tzavella K; Schenkirsch G; Riepl RL; Odenthal KP; Leng-Peschlow E; Müller-Lissner SA
Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):13-20. PubMed ID: 7532534
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study).
Mathus-Vliegen EMH; van der Vliet K; Wignand-van der Storm IJ; Stadwijk JS
Dis Colon Rectum; 2018 Feb; 61(2):239-249. PubMed ID: 29337780
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets.
Yang K; Fan K; Newmark H; Leung D; Lipkin M; Steele VE; Kelloff GJ
Cancer Res; 1996 Oct; 56(20):4644-8. PubMed ID: 8840978
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of bowel-cleansing agents: implications of antibacteroides activity of senna.
Chapman MA; Abercrombie J; Livermore DM; Williams NS
Br J Surg; 1995 Aug; 82(8):1053. PubMed ID: 7648151
[No Abstract] [Full Text] [Related]
12. [Mechanism of action of sennosides].
Lemli J
Bull Acad Natl Med; 1995 Nov; 179(8):1605-11. PubMed ID: 8717178
[TBL] [Abstract][Full Text] [Related]
13. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation.
Beyer J; Peters FT; Maurer HH
Ther Drug Monit; 2005 Apr; 27(2):151-7. PubMed ID: 15795644
[TBL] [Abstract][Full Text] [Related]
14. Acceleration of large intestine transit time in rats by sennosides and related compounds.
Leng-Peschlow E
J Pharm Pharmacol; 1986 May; 38(5):369-73. PubMed ID: 2872313
[TBL] [Abstract][Full Text] [Related]
15. [The mechanism of action of sennosides].
Lemli J
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):109-12. PubMed ID: 8737510
[TBL] [Abstract][Full Text] [Related]
16. Sennoside-induced secretion is not caused by changes in mucosal permeability or Na+,K(+)-ATPase activity.
Leng-Peschlow E
J Pharm Pharmacol; 1993 Nov; 45(11):951-4. PubMed ID: 7908035
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cell proliferation and prostaglandin biosynthesis by 1,8-dihydroxyanthraquinone in the rat large intestine.
Nishikawa A; Kase Y; Hayakawa T; Yanagisawa T; Kanno J; Hayashi Y
Carcinogenesis; 1997 Jun; 18(6):1259-63. PubMed ID: 9214611
[TBL] [Abstract][Full Text] [Related]
18. Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I study.
Rex DK; Katz PO; Bertiger G; Vanner S; Hookey LC; Alderfer V; Joseph RE
Gastrointest Endosc; 2013 Jul; 78(1):132-41. PubMed ID: 23566639
[TBL] [Abstract][Full Text] [Related]
19. Some aspects of the pharmacology of anthraquinone drugs.
van Os FH
Pharmacology; 1976; 14 Suppl 1():18-29. PubMed ID: 790404
[No Abstract] [Full Text] [Related]
20. Current concepts of laxative action: mechanisms by which laxatives increase stool water.
Donowitz M
J Clin Gastroenterol; 1979 Mar; 1(1):77-84. PubMed ID: 95606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
